Trials / Completed
CompletedNCT04228432
E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer.
E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer: Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Institut Claudius Regaud · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a monocentric, prospective cohort study evaluating the feasibility of an E-monitoring protocol in patients with breast cancer treated by adjuvant hormonotherapy . 45 patients will be included. Patients will be followed during 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dedicated and coordinated monitoring | * Coordinated monitoring performed by a dedicated nurse: consultation before hormonotherapy initiation * Monitoring at home over a period of 6 months using an e-monitoring tool: assessment of adverse events and completion of GIRERD questionnaire at week 3 and week 6. |
Timeline
- Start date
- 2020-02-28
- Primary completion
- 2021-07-21
- Completion
- 2021-07-21
- First posted
- 2020-01-14
- Last updated
- 2021-07-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04228432. Inclusion in this directory is not an endorsement.